Drugs / elbasvir/grazoprevir
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03105349 | Jul → Dec 2017 | hepatitis C virus infection | Fundacion SEIMC-GESIDA | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | elbasvir/grazoprevir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03105349 ↗ |